Multicenter phase II trial of pembrolizumab (pembro) in previously-treated metastatic esophageal cancer.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Peter C. Enzinger, Nadine Jackson McCleary, Nora Horick, James M. Cleary, Douglas Adam Rubinson, Bridget Fitzpatrick, Christopher Graham, Jeffrey W. Clark, Anuj K. Patel, Eirini Pectasides, Kimberly Perez, Matthew B. Yurgelun, Christopher G. Azzoli, Andrea Catherine Enzinger, Justin F. Gainor, Benjamin L. Schlechter, Jeffrey A. Meyerhardt, Kimmie Ng, Adam Joel Bass, Charles S. Fuchs
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890079918
